AMPICILLIN TRIHYDRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ampicillin Trihydrate, and when can generic versions of Ampicillin Trihydrate launch?
Ampicillin Trihydrate is a drug marketed by Aurobindo Pharma, Belcher Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Sandoz, Strides Pharma Intl, Vitarine, Ph Health, and Teva. and is included in sixteen NDAs.
The generic ingredient in AMPICILLIN TRIHYDRATE is ampicillin/ampicillin trihydrate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMPICILLIN TRIHYDRATE?
- What are the global sales for AMPICILLIN TRIHYDRATE?
- What is Average Wholesale Price for AMPICILLIN TRIHYDRATE?
Summary for AMPICILLIN TRIHYDRATE
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 16 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 1 |
| Patent Applications: | 606 |
| DailyMed Link: | AMPICILLIN TRIHYDRATE at DailyMed |
Recent Clinical Trials for AMPICILLIN TRIHYDRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for AMPICILLIN TRIHYDRATE
| Drug Class | Penicillin-class Antibacterial |
US Patents and Regulatory Information for AMPICILLIN TRIHYDRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purepac Pharm | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 061980-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | FOR SUSPENSION;ORAL | 061370-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 216554-001 | Oct 31, 2023 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma Intl | AMPICILLIN TRIHYDRATE | ampicillin/ampicillin trihydrate | CAPSULE;ORAL | 062882-001 | Feb 25, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
